Displaying drugs 476 - 500 of 2781 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Pentetreotide | 1394.58 C63H87N13O19S2 | A somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours. | Radiopharmaceuticals / Terbium | |
Asciminib | 449.84 C20H18ClF2N5O3 | An inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. | Bcr-Abl Tyrosine Kinase Inhibitors / Tyrosine Kinase Inhibitors | |
Mebeverine | 429.557 C25H35NO5 | An antispasmodic used for the symptomatic treatment of stomach pain and spasms associated with irritable bowel syndrome and other gastrointestinal illnesses. | Synthetic Anticholinergics, Esters With Tertiary Amino Group | |
Sparsentan | 592.76 C32H40N4O5S | An endothelin and angiotensin II receptor antagonist indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. | Agents Acting on the Renin-Angiotensin System / Amides / Angiotensin 2 Receptor Blocker / Angiotensin II receptor antagonists / Angiotensin II Type 1 Receptor Blockers / Angiotensin Receptor Antagonists / BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA) / Endothelin Receptor Antagonists / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / Sulfones / Sulfur Compounds | |
Samidorphan | 370.449 C21H26N2O4 | A novel opioid-system modulator, similar to naltrexone, that functions primarily as a μ-opioid receptor antagonist in vivo and is used primarily in combination with antipsychotics to reduce their metabolic dysfunction-associated adverse effects. | Diazepines, Oxazepines, Thiazepines and Oxepines | |
1,2-Benzodiazepine | 144.177 C9H8N2 | Benzodiazepine is under investigation for the prevention of Delirium and C.Surgical Procedure; Cardiac. Benzodiazepine has been investigated for the treatment of Obesity, Sleep Apnea, Obstructive, and Disorders of Gallbladder, Biliary... | Benzazepines / Benzodiazepines and benzodiazepine derivatives / Benzodiazepines, antagonists & inhibitors | |
Oxetacaine | 467.654 C28H41N3O3 | An antacid used to treat gastritis, peptic ulcer disease, heartburn, esophagitis, hiatus hernia, and anorexia. | Anesthetics, Local | |
Nitrite | 46.0055 NO2 | Nitrite is under investigation for the treatment of Heart Failure. | Anions | |
Mizolastine | 432.503 C24H25FN6O | A second-generation non-sedating antihistamine used to treat symptoms of allergic rhinoconjunctivitis and urticaria. | Histamine H1 Antagonists, Non-Sedating | |
Omaveloxolone | 554.723 C33H44F2N2O3 | A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. | Anti-Inflammatory Agents / Antioxidants / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / OAT1/SLC22A6 inhibitors / Oxidation-Reduction Agent / Terpenes / Triterpenes | |
Fedratinib | 524.678 C27H36N6O3S | Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.[L8090,L47016] | Janus Kinase Inhibitor / Protein Kinase Inhibitors | |
Clascoterone | 402.531 C24H34O5 | An androgen receptor antagonist used for the topical treatment of acne vulgaris in patients 12 years of age and older. | Androgen Receptor Inhibitors | |
Piritramide | 430.5851 C27H34N4O | A synthetic opioid used in the treatment of severe pain. | Diphenylpropylamine Derivatives | |
Copanlisib | 480.529 C23H28N8O4 | A PI3K inhibitor used to treat relapsed follicular lymphoma in adults. | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | |
Betulinic Acid | 456.711 C30H48O3 | Betulinic Acid has been used in trials studying the treatment of Dysplastic Nevus Syndrome. | Agents that produce hypertension | |
Lynestrenol | 284.443 C20H28O | A progestin used for contraception and in the treatment of menstrual disorders. | Estren Derivatives / Progestins / Progestogens and Estrogens, Sequential Preparations | |
Taurolidine | 284.35 C7H16N4O4S2 | An antimicrobial derivative of taurine used for prophylaxis of catheter-related infections. | Anti-Infective Agents | |
Ibrexafungerp | 730.051 C44H67N5O4 | A triterpene antifungal indicated in the treatment of vulvovaginal candidiasis and prevention of recurrent vulvovaginal candidiasis in post-menarchal patients. | Antifungal Agents / Triterpenoid Antifungal | |
Favipiravir | 157.104 C5H4FN3O2 | An antiviral used to manage influenza, and that has the potential to target other viral infections. | Antiviral Agents | |
Rimegepant | 534.568 C28H28F2N6O3 | An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults. | Calcitonin Gene-Related Peptide (CGRP) Antagonists | |
Omadacycline | 556.66 C29H40N4O7 | A tetracycline antibiotic used to treat community acquired bacterial pneumonia. | Tetracyclines | |
Steviolbioside | 642.739 C32H50O13 | Steviolbioside has been used in trials studying the treatment of HIV-1 Infection. | Stevia / Sweetening Agents | |
Iobitridol | 835.169 C20H28I3N3O9 | An iodine-based contrast agent used with X-ray or CT imaging. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media | |
Remimazolam | 439.313 C21H19BrN4O2 | An ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures. | Benzodiazepines and benzodiazepine derivatives | |
Bromperidol | 420.322 C21H23BrFNO2 | A first-generation butyrophenone antipsychotic used in the treatment of schizophrenia and other psychotic manifestations. | Butyrophenone Derivatives |
Displaying drugs 476 - 500 of 2781 in total